Stay updated with breaking news from Storage Disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day 08.09.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Moderna Reviews Clinical Trial Programs Across Port...
Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefitInterim data from
Objectives: To determine the frequency of clinical presentation and laboratory profile in the diagnosis of the etiological spectrum of neonatal cholestasis. Material and methods: In this prospective cross-sectional study, we recruited children who presented with jaundice and direct hyperbilirubinemia with onset in the first three months of life. The study was conducted between April 2019 to March 2021 (24 months) at the Government Lady Reading Hospital of Khyber Pakhtunkhwa province in Pakistan. The diagnosis was based on history and clinical findings that included jaundice, stool color, it...
Each Center for Excellence was selected by NORD in a competitive application process requiring evidence of experience and expertise across multiple specialties to meet the needs of rare disease patients and a history of significant contributions to rare disease patient education, physician training and research.
